WILLIAM BLAIR INVESTMENT MANAGEMENT LLC 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-09 3:18 pm Sale | 2025-12-31 | 13G | AMICUS THERAPEUTICS INC FOLD | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 10,627,717 3.400% | -5,346,537 (-33.47%) | Filing |
| 2025-11-12 6:08 pm Purchase | 2025-09-30 | 13G | AMICUS THERAPEUTICS INC FOLD | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 15,974,254 5.200% | 1,195,603 (+8.09%) | Filing |
| 2025-05-09 4:47 pm Sale | 2025-03-31 | 13G | AMICUS THERAPEUTICS INC FOLD | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 14,778,651 4.900% | -804,311 (-5.16%) | Filing |
| 2024-11-14 11:37 am Purchase | 2024-09-30 | 13G | AMICUS THERAPEUTICS INC FOLD | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 15,582,962 5.300% | 15,582,962 (New Position) | Filing |